ArticleJournal of managed care & specialty pharmacy2021

Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.

Daniel G Whitney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.